Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge
Authors:
Open Access
- 18 January 2021
- journal article
- letter
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 25 (1) , 104-105
Abstract
How to cite this article: Prakash J, Bhattacharya PK, Priye S, Kumar N. Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge. Indian J Crit Care Med 2021;25(1):104–105.Keywords
This publication has 5 references indexed in Scilit:
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapyThe Lancet Respiratory Medicine, 2020
- Pulmonary fibrosis secondary to COVID-19: a call to arms?The Lancet Respiratory Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Pulmonary fibrosis: Cellular and molecular eventsPathology International, 2003
- Fibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and TreatmentClinical Immunology, 2001